Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Fuller, Ray W."'
Autor:
Kostrzewa, Richard M., Fukushima, Hideki, Harston, Craig T., Perry, Kenneth W., Fuller, Ray W., Kastin, Abba J.
Publikováno v:
ETSU Faculty Works.
Because of conflicting reports of the actions of the antiparkinsonian agent L-prolyl-L-leucyl-glycine amide (PLG, MIF-I) on the turnover of Striatal dopamine (DA), this process was reinvestigated. In the present series of studies, it was found that n
Externí odkaz:
https://dc.etsu.edu/etsu-works/13209
Publikováno v:
ETSU Faculty Works.
Dopamine (DA) neurons are implicated in the hyperlocomotion of neonatal 6-hydroxydopamine (6-OHDA)-lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD). Because serotonin (5-HT) neurons mediate some DA agonist effects, we
Externí odkaz:
https://dc.etsu.edu/etsu-works/13193
Publikováno v:
ETSU Faculty Works.
Neonatal 6-hydroxydopamine (6-OHDA) treatment is associated with destruction of dopamine (DA) fibers and subsequent sprouting of serotonin (5-HT) fibers in the striatum of rats. Enhanced oral activity responses to SKF 38393 and m-chlorophenylpiperazi
Externí odkaz:
https://dc.etsu.edu/etsu-works/12794
Publikováno v:
ETSU Faculty Works.
Neonatal 6-hydroxydopamine (6-OHDA) treatment of rats is associated with supersensitization of the dopamine (DA) D1 agonist induction of stereotyped and locomotor behaviors. The present study was conducted to determine whether ontogenetic treatments
Externí odkaz:
https://dc.etsu.edu/etsu-works/12795
Publikováno v:
ETSU Faculty Works.
Neonatal 6-hydroxydopamine (6-OHDA) treatment of rats is associated with concurrent supersensitization of dopamine (DA) D1 and serotonin 5-HT1C receptors, for agonist-induced oral activity. The present study was conducted to determine if graded reduc
Externí odkaz:
https://dc.etsu.edu/etsu-works/12793
Publikováno v:
ETSU Faculty Works.
To investigate the influence of dopamine (DA) nerves on haloperidol (HAL)-induced oral dyskinesias, rats were first injected at 3 days after birth with 6-hydroxydopamine HBr (200 μg i.c.v., salt form; 6-OHDA) or vehicle, after desipramine HCl (20 mg
Externí odkaz:
https://dc.etsu.edu/etsu-works/10859
Autor:
Fuller, Ray W., Hemrick-Luecke, Susan
Publikováno v:
Science, 1980 Jul 01. 209(4453), 305-307.
Externí odkaz:
https://www.jstor.org/stable/1684941
Publikováno v:
Science, 1962 Sep . 137(3533), 868-869.
Externí odkaz:
https://www.jstor.org/stable/1710303
Autor:
Fuller, Ray W.
Publikováno v:
Science, 1970 Mar . 167(3925), 1562-1564.
Externí odkaz:
https://www.jstor.org/stable/1729121
Autor:
Fuller, Ray W., Snoddy, Harold D.
Publikováno v:
Science, 1968 Feb . 159(3816), 738-738.
Externí odkaz:
https://www.jstor.org/stable/1723190